|
TCMBANKIN057949 |
sucrose |
Amerfand; 29253-78-9; Sucrose (TN); alpha-D-Glucopyranoside, beta-D-fructofuranosyl-; saccharose; Sugar, compressible (NF); S0389_SIGMA; D06530; C00089; 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside; Sucrose, purified; 8027-47-2; 30027-72-6; 29764-06-5; 86101-30-6; NSC 406942; D06529; Sucrose [USAN:JAN]; 146187-04-4; ST5308554; Sugar, confectioner's; D(+)-Saccharose; S7903_SIGMA; GLC-(1-2)FRU; alpha-D-glucopyranosyl beta-D-fructofuranoside; FICOLL; 151756-02-4; Sugar spheres (NF); White soft sugar (JP15); Sucraloxum [INN-Latin]; Saccharum; alpha-D-Glc-(1-2)-beta-D-Fru; S9378_SIGMA; 76056-38-7; 47289_SUPELCO; D-Sucrose; Sugar spheres; 87430-66-8; 104242-10-6; (alpha-D-Glucosido)-beta-D-fructofuranoside; Table sugar; Sacharose; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; NCI-C56597; 47167-52-2; CCRIS 2120; alpha-D-Glucopyranoside, beta-D-fructofuranosyl, homopolymer; D06528; Microse; Cane sugar; Amerfond; 64533-66-0; White soft sugar; beta-D-Fruf-(2<->1)-alpha-D-Glcp; sugar; White sugar; SUC; 84097_FLUKA; Rock candy; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; Fructofuranoside, alpha-D-glucopyranosyl, beta-D; 80165-03-3; 47257-91-0; CHEBI:17992; 47185-09-1; S5390_SIGMA; alpha-D-Glucopyranoside, beta-D-fructofuranosyl; S1888_SIGMA; 220376-22-7; D06533; 8030-20-4; S3929_SIGMA; S1174_SIGMA; 65545-99-5; Glucopyranoside, beta-D-fructofuranosyl, alpha-D; S2395_SIGMA; 78654-77-0; D06531; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; SUCROSE; S5016_SIAL; 51909-69-4; 85456-51-5; D()-Saccharose; ZINC04217475; 84100_FLUKA; D00025; Confectioner's sugar; EINECS 200-334-9; Sugar, confectioner's (NF); 57-50-1; 100405-08-1; 92004-84-7; Beet sugar; S5391_SIGMA; Sucrose, dust; alpha-D-Glc-(1->2)-beta-D-Fru; beta-D-Fructofuranosyl alpha-D-glucopyranoside; 131932-12-2; HSDB 500; Sugar, compressible; AI3-09085; alpha-D-Glucopyranosylbeta-D-fructofuranoside; Rohrzucker; 16104_RIEDEL; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; Granulated sugar; S8501_SIGMA; Sucrose, purified (JAN); 146054-35-5; Sucrose (JP15/NF); 9012-95-7; Sucrose, pure; 75398-84-4; 50857-68-6; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 25702-74-3; D(+)-Sucrose |
C12H22O11 |
342.3 g/mol |
C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O |
|
TCMBANKIN058205 |
trans-resveratrol |
(E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; SRT501; AX8004672; DB02709; RP17549; NCGC00017352-05; NCGC00017352-13; NCGC00017352-19; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 4CN-0696; I06-0437; 3,4',5-Trihydroxy-trans-stilbene; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; s1396; HMS1990H15; SAM001246888; CPD000058206; CU-01000001503-3; BPBio1_000479; NCGC00024003-14; (E)-5-(p-Hydroxystyryl)resorcinol; FT-0082623; Tox21_501111; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 01R360; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Tox21_303376; MLS001055357; NCGC00024003-13; GP5884; A827984; resveratrol; NCGC00017352-09; NCGC00017352-15; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; NCGC00024003-11; D0U3EP; ACN-034773; ST057251; EU-0101111; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; HY-16561; N1848; ACT09778; NCGC00017352-17; BRD-K80738081-001-09-6; KUC104385N; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; STL; MLS001424228; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; HMS1569F17; Resveratrol, Vetec(TM) reagent grade, 98%; HMS1921N04; IDI1_002152; Resvida; KB-02515; SR-01000000163-10; NCGC00017352-08; AB00052942_31; 3,5,4'-Trihydroxystilbene; trans-Stilbene-3,4',5-triol; Tox21_110257; NCGC00024003-12; trans-3,4′,5-Trihydroxystilbene; trans-3,4',5 - trihydroxystilbene; ZB000650; ZINC6787; DSSTox_RID_78898; NCGC00024003-09; 3fts; BB_NC-2570; SRT-501; ZX-AS004941; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; BRD-K80738081-001-23-7; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; NSC327430; LS-2146; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; NCGC00024003-04; DSSTox_CID_11980; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Prestwick3_000508; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; Resveratrol, European Pharmacopoeia (EP) Reference Standard; NCGC00015894-02; ARONIS24568; STL146386; R 5010; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; AC1L9HIC; BSPBio_003461; REGID_for_CID_445154; C14H12O3; SR-01000000163-11; 501-36-0; C03582; SRT 501; NSC 327430; NSC-327430; Spectrum5_000552; AS-12413; Trans-3,4′ NCGC00024003-06; AKOS005720936; BG01529320; BBC/741; HMS1792H15; NCGC00258925-01; TL8003323; AB00052942-29; SR-01000000163-4; SR-01000000163-16; BSPBio_000435; Opera_ID_586; NC00349; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; ZX-AT013797; 375823-41-9; HMS3403H15; 3,4',5-Trihydroxystilbene; HMS2232A18; KSC-10-164; AN-865; LMPK13090005; AJ-08292; OR46018; R0071; CHEMBL165; BRD-K25591257-001-01-2; Resveratrol, E-; BBL028252; NCGC00024003-05; LP01111; UNII-Q369O8926L; CCG-38874; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MFCD00133799; 2l98; BDBM23926; SGCUT00007; GP2549; Resveratrol, trans-; CC-34242; ST2408097; MLS001076538; AK-39118; HMS1362H15; NCGC00024003-07; ABP000376; SBB055452; NCGC00017352-16; trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Tox21_110257_1; BRD-K80738081-001-06-2; Resveratrol, certified reference material, TraceCERT(R); 3,4',5-Stilbenetriol; MCULE-5678456463; J10118; BSPBio_001114; HMS2052I09; Resveratrol, >=99% (HPLC); CS-1050; SCHEMBL19425; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; Resveratol; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; HMS3263O04; 4jaz; AB0006623; CAS-501-36-0; CCRIS 8952; MLS000069735; trans-3,4',5-trihydroxystilbene; 4qer; Tox21_201374; to_000079; SPECTRUM1502223; BC202036; API0000480; NCGC00017352-10; CHEBI:27881; NCGC00017352-24; SY014849; 3,4',5-trihydroxy-stilbene; NCGC00017352-06; PREVENTION 8 (RESVERATROL); MolPort-002-499-801; (E)-resveratrol; BCPP000091; Prestwick_619; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; SMR000058206; cid_445154; Q369O8926L; Resveratrol, analytical standard; DSSTox_GSID_31980; NCGC00017352-11; AC-727; HMS2096F17; BS0159; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; BRD-K80738081-001-10-4; NCGC00017352-12; MLS002222231; Resveratrol, natural; Lopac0_001111; BR-39118; CJ-00111; NCGC00017352-07; DTXSID4031980; CR-003; Stilbene, 2f; NCGC00017352-18; NCGC00024003-10; SC-11924; SR-01000000163-3; MLS002207121; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; NCGC00024003-00; HMS3649A20; KS-5047; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; NCGC00017352-14; HSDB 7571; NCGC00024003-08; 533C1DA0-4104-42B5-9D32-9265F40857E4; RM-1812; REGID_for_CID_6240; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; BIK9013; NCGC00257465-01; GTPL8741; BG00606847; NCGC00261796-01; CHEBI:45713; SR-01000000163; Resveratrol, synthetic; SR-01000000163-9; Prestwick2_000508; N88795; 3,5,4'-Trihydroxy-trans-stilbene; resveratrol; 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-; cis-3,5,4'-trihydroxystilbene; AIDS025474; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; SPBio_002356; BPBio1_000479; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Spectrum4_001896; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; EU-0101111; ST057251; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; resveratrol ; KBioSS_000454; 1684AH; Spectrum3_001821; STL; CHEBI:36002; SPBio_001513; IDI1_002152; Prestwick1_000508; 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E; 3,5,4'-Trihydroxystilbene; 3,4',5-trihydroxy stilbene; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; trans-3,4′,5-Trihydroxystilbene; 31100-06-8; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Cis resveratrol; SRT-501; NSC327430; 3,4′,5-Trihydroxy-trans-stilbene; Spectrum_001148; 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00024003-04; Prestwick3_000508; NCGC00015894-02; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00017352-03; SCHEMBL1931746; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; BSPBio_003461; Bio2_000877; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-; 31100-06-8 (DELETED); Z-Resveratrol; UNII-AUA0K06FSB; 501-36-0; C03582; AKOS025395422; KBio2_004196; KBio3_002965; Prestwick0_000508; NSC 327430; 34092_RIEDEL; KBio3_000848; NCGC00017352-02; Spectrum5_000552; MolPort-003-850-143; NCGC00024003-06; KBio2_005590; SpecPlus_000391; AC1LU7HY; AUA0K06FSB; KBioGR_000454; AIDS-025474; BSPBio_000435; cis-resveratrol; KBio2_006764; KBio2_001628; KBioGR_002457; CHEMBL87333; 3,4',5-Trihydroxystilbene; Lopac-R-5010; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; KBio2_000454; Resveratrol, (Z)-; SGCUT00007; CJ-13797; NCGC00024003-07; Resveratrol (Z)-form [MI]; NCGC00017352-01; I14-7425; DivK1c_006487; MolMap_000045; 3,4',5-Stilbenetriol; Oprea1_727238; Tocris-1418; DB-072954; NCGC00017352-04; BSPBio_001114; BDBM50131698; 434C671; LUKBXSAWLPMMSZ-UPHRSURJSA-; KBio3_000847; CAS-501-36-0; SMP1_000257; 4q93; MLS000069735; cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol; ZINC00006787; (Z)-3,5,4'-trihydroxystilbene; to_000079; SPECTRUM1502223; trans-Resveratrol; R5010_SIGMA; KBio2_003022; 61434-67-1; NCGC00024003-02; NCGC00015894-01; CHEBI:27881; Resveratrol; AC-24235; (E)-resveratrol; Prestwick_619; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol; SMR000058206; TNP00294; Resveratrol, Z-; ZINC12353732; Lopac0_001111; cis-3,4',5-trihydroxystilbene; NCI60_002840; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol; Bio2_000397; NCGC00024003-00; (Z)-3,4',5-trihydroxystilbene; 3,5-Dihydroxy-4'-methoxystilbene; 3, 5,4'-trihydroxy-trans-stilbene; cis-3,4,5-Trihydroxystilbene; NCGC00024003-08; RM-1812; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; KBioSS_001628; KBio1_001431; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEBI:45713; Spectrum2_001497; Prestwick2_000508; 3,5,4'-Trihydroxy-trans-stilbene |
C14H12O3 |
228.24 g/mol |
C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O |
|
TCMBANKIN058259 |
p-aminophenol;para-aminophenol |
4-AMINO-PHENOL; Tox21_113477; SBB059792; para aminophenol; Fourrine 84; AS04549; 9225-EP2275420A1; DSSTox_GSID_24499; 4-Aminophenol (Acetaminophen Related Compound K) (Paracetamol Impurity K), Pharmaceutical Secondary Standard; Certified Reference Material; Certinal; AKOS000119829; p-Aminofenol; 4-Aminophenol, >=99% (HPLC); AN-24398; CJ-12175; BDBM26195; ST088538; J-004908; FT-0617593; A0384; Benzofur P; Aminophenol, p-; NSC-1545; BB_SC-6973; AKOS016371265; AK-46590; KB-189354; CCRIS 4146; to_000006; BASF Ursol P Base; DSSTox_CID_4499; Tox21_201030; 4NL; ACMC-209aoj; SCHEMBL3424; Para-aminophenol; 4-amino phenol; p-aminobenzenol; Tertral P Base; CI 76550; Acetaminophen Impurity K; BG00599911; 4-aminophenol; 9225-EP2280008A2; p-Aminophenol [UN2512] [Poison]; bmse000462; Phenol, p-amino-; para-hydroxyaniline; AC1Q523U; 4-aminophenol?; Pelagol CP (Salt/Mix); 1-Amino-4-hydroxybenzene; AB1009438; TRA0083709; para-amino-phenol; Phenol, 4-amino-; NCGC00090816-05; 9225-EP2308872A1; Epitope ID:117708; Pelagol Grey CP (Salt/Mix); Ursol P; UNII-R7P8FRP05V; AM86423; NCGC00090816-02; Pelagol Grey P Base; CAS-123-30-8; SGCUT00256; Tox21_113477_1; HSDB 2640; R7P8FRP05V; AJ-333/25022099; Nako Brown R; p-Aminophenol [UN2512] [Poison]; Zoba Brown P Base; AI3-14872; 9225-EP2316829A1; Kodelon; 63084-98-0 (sulfate [2:1]); ST2405553; TR-003672; Takatol; ANW-18113; Rodinal; F2190-0438; NCGC00090816-01; Tox21_113242; J-514454; BBL011574; NCGC00090816-03; 4-hydroxy-aniline; C.I. 76550; 135807-EP2371803A1; PubChem22199; MFCD00007869; 4-Aminophenol, PESTANAL(R), analytical standard; 4-aminobenzenol; phenol derivative, 9; C.I. Oxidation Base 6A; C.I. Oxidation Base 6; PLIKAWJENQZMHA-UHFFFAOYSA-N; Durafur Brown R (Salt/Mix); paraaminophenol; 51-78-5 (hydrochloride); Pelagol P Base; Energol; 4-hydroxyphenylamine; SC-19013; 4-Aminophenol, >=98%; Furro P (Salt/Mix); Fouramine P; p-amino-phenol; Futramine P (Salt/Mix); Paramidophenol; 4-Aminophenol, technical grade, 95%; UN 2512; AC1Q523T; KB-79942; p-hydroxyaniline; AN-22912; Phenol,4-amino-; NSC1545; 4-hydroxyaniline; RP18925; 123-30-8; p-Aminofenol [Czech]; Z57127517; 4-Aminophenol, 250 mug/mL in acetonitrile, certified reference material, ampule of 1 mL; CHEMBL1142; L-1224; AJ-51764; MLS001066356; Durafur Brown RB; I01-0483; NCGC00258583-01; Fourrine P Base; CS-0006652; LS-676; STK286017; 135807-EP2377843A1; MCULE-3319647085; Para Amino Phenol; I924; KS-000000HN; WLN: ZR DQ; Citol; InChI=1/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H; NSC 1545; Ursol P Base; MolPort-001-641-054; Furro P Base; ZINC4623758; 4-Amino-1-hydroxybenzene; AC1L195P; Azol; p-Hydroxyphenylamine; Renal AC; UNAL; DTXSID3024499; C02372; KSC354Q5H; 4-Aminophenol, United States Pharmacopeia (USP) Reference Standard; SMR000471841; Peltol P (Salt/Mix); NCGC00090816-04; 52985-09-8; DSSTox_RID_77429; BC227837; Paranol; D07MTM; UNII-LST7140D72 component PLIKAWJENQZMHA-UHFFFAOYSA-N; EINECS 204-616-2; Mesalazine impurity A, European Pharmacopoeia (EP) Reference Standard; EC 204-616-2; CHEBI:17602;4-aminophenol; 4-AMINO-PHENOL; ZINC04623758; 35837_RIEDEL; Durafur Brown RB; Phenol, p-amino-; C.I. 76550; Fourrine P Base; AIDS019902; STK286017; A71328_ALDRICH; 1-Amino-4-hydroxybenzene; CPD-259; Fourrine 84; 4-aminobenzenol; WLN: ZR DQ; c0090; InChI=1/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H; C.I. Oxidation Base 6; p-aminophenol; Citol; NSC 1545; Ursol P Base; Certinal; Pelagol P Base; Furro P Base; Phenol, 4-amino-; p-Aminofenol; Fouramine P; Ursol P; 4-Amino-1-hydroxybenzene; Pelagol Grey P Base; CI 76550; p-Hydroxyphenylamine; Azol; Benzofur P; SGCUT00256; Aminophenol, p-; Renal AC; HSDB 2640; AJ-333/25022099; C02372; CCRIS 4146; to_000006; p-hydroxyaniline; p-Aminophenol [UN2512] [Poison]; SMR000471841; BASF Ursol P Base; Nako Brown R; NSC1545; 60034_RIEDEL; 4-hydroxyaniline; Zoba Brown P Base; 123-30-8; 4NL; p-Aminofenol [Czech]; AI3-14872; 52985-09-8; AIDS-019902; Paranol; p-aminobenzenol; Tertral P Base; EINECS 204-616-2; Rodinal; CHEBI:17602; MLS001066356; 51-78-5 (HCL); NCGC00090816-01;4-AMINO-PHENOL; Tox21_113477; SBB059792; para aminophenol; Fourrine 84; AS04549; 9225-EP2275420A1; DSSTox_GSID_24499; p-aminophenol; 4-Aminophenol (Acetaminophen Related Compound K) (Paracetamol Impurity K), Pharmaceutical Secondary Standard; Certified Reference Material; Certinal; AKOS000119829; p-Aminofenol; 4-Aminophenol, >=99% (HPLC); AN-24398; CJ-12175; BDBM26195; ST088538; J-004908; FT-0617593; A0384; Benzofur P; Aminophenol, p-; NSC-1545; BB_SC-6973; AKOS016371265; AK-46590; KB-189354; CCRIS 4146; to_000006; BASF Ursol P Base; DSSTox_CID_4499; Tox21_201030; 4NL; ACMC-209aoj; SCHEMBL3424; Para-aminophenol; 4-amino phenol; p-aminobenzenol; Tertral P Base; CI 76550; Acetaminophen Impurity K; BG00599911; 4-aminophenol; 9225-EP2280008A2; p-Aminophenol [UN2512] [Poison]; bmse000462; Phenol, p-amino-; para-hydroxyaniline; AC1Q523U; 4-aminophenol?; Pelagol CP (Salt/Mix); 1-Amino-4-hydroxybenzene; AB1009438; TRA0083709; para-amino-phenol; Phenol, 4-amino-; NCGC00090816-05; 9225-EP2308872A1; Epitope ID:117708; Pelagol Grey CP (Salt/Mix); Ursol P; UNII-R7P8FRP05V; AM86423; NCGC00090816-02; Pelagol Grey P Base; CAS-123-30-8; SGCUT00256; Tox21_113477_1; HSDB 2640; R7P8FRP05V; AJ-333/25022099; Nako Brown R; p-Aminophenol [UN2512] [Poison]; Zoba Brown P Base; AI3-14872; 9225-EP2316829A1; Kodelon; 63084-98-0 (sulfate [2:1]); ST2405553; TR-003672; Takatol; ANW-18113; Rodinal; F2190-0438; NCGC00090816-01; Tox21_113242; J-514454; BBL011574; NCGC00090816-03; 4-hydroxy-aniline; C.I. 76550; 135807-EP2371803A1; PubChem22199; MFCD00007869; 4-Aminophenol, PESTANAL(R), analytical standard; 4-aminobenzenol; phenol derivative, 9; C.I. Oxidation Base 6A; C.I. Oxidation Base 6; PLIKAWJENQZMHA-UHFFFAOYSA-N; Durafur Brown R (Salt/Mix); paraaminophenol; 51-78-5 (hydrochloride); Pelagol P Base; Energol; 4-hydroxyphenylamine; SC-19013; 4-Aminophenol, >=98%; Furro P (Salt/Mix); Fouramine P; p-amino-phenol; Futramine P (Salt/Mix); Paramidophenol; 4-Aminophenol, technical grade, 95%; UN 2512; AC1Q523T; KB-79942; p-hydroxyaniline; AN-22912; Phenol,4-amino-; NSC1545; 4-hydroxyaniline; RP18925; 123-30-8; p-Aminofenol [Czech]; Z57127517; 4-Aminophenol, 250 mug/mL in acetonitrile, certified reference material, ampule of 1 mL; CHEMBL1142; L-1224; AJ-51764; MLS001066356; Durafur Brown RB; I01-0483; NCGC00258583-01; Fourrine P Base; CS-0006652; LS-676; STK286017; 135807-EP2377843A1; MCULE-3319647085; Para Amino Phenol; I924; KS-000000HN; WLN: ZR DQ; Citol; InChI=1/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H; NSC 1545; Ursol P Base; MolPort-001-641-054; Furro P Base; ZINC4623758; 4-Amino-1-hydroxybenzene; AC1L195P; Azol; p-Hydroxyphenylamine; Renal AC; UNAL; DTXSID3024499; C02372; KSC354Q5H; 4-Aminophenol, United States Pharmacopeia (USP) Reference Standard; SMR000471841; Peltol P (Salt/Mix); NCGC00090816-04; 52985-09-8; DSSTox_RID_77429; BC227837; Paranol; D07MTM; UNII-LST7140D72 component PLIKAWJENQZMHA-UHFFFAOYSA-N; EINECS 204-616-2; Mesalazine impurity A, European Pharmacopoeia (EP) Reference Standard; EC 204-616-2; CHEBI:17602;p-aminophenol;para-aminophenol |
C6H7NO |
109.13 g/mol |
C1=CC(=CC=C1N)O |
|
TCMBANKIN058450 |
ADO |
nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside |
C10H13N5O4 |
267.24 g/mol |
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
滇IICP备16009434号-1 |
Dai SX Lab